The experts in our R&D organisation work across specialised teams that join forces to bring innovations forward. Our Research team uses cutting-edge science to ensure strong human validation of our targets and optimisation of our lead structures. The experts in our Development team create leading development strategies for our compounds that lay the basis for a successful market approval.

The Portfolio Management & Business Development team maximises the value of our portfolio by driving our projects to success and tapping into the best external innovation opportunities.

Scientists and medical doctors at our Innovation Hub in Boston approach their work with the agility and entrepreneurial mindset you might expect from a small biotech company. Together, they strengthen our company’s access to the latest science by conducting exciting projects and engaging in close collaboration with innovative partners.

Our Drug Safety department puts patients at the centre of everything it does. The team ensures patient safety for Grünenthal’s brands worldwide, and has representatives in all of Grünenthal’s affiliates, as well as at our headquarters in Aachen. They are involved in all phases of a product’s life cycle, and they leverage their deep medical and pharmaceutical expertise, as well as their expert knowledge of international and national guidelines.

Our Regulatory Affairs department brings together passionate, highly skilled and experienced colleagues who are located across countries and regions. They develop fit-for-purpose regulatory strategies that can successfully deliver marketing authorisations for our investigational medicines. This makes it possible for our treatments to make a life-changing positive impact on patients and their families. 

Of course, joining forces is part of our company culture. Our people in R&D work in close collaboration with their Grünenthal colleagues in Commercial and Global Operations, and they are constantly supported by functions like Procurement, Quality Assurance and IT.